Elicio Therapeutics, Inc. (ELTX )

Currency in USD Disclaimer
$14.2 +$0.65 (4.8%)
Closed 06/09/2026
$12.76
$14.2
$7.37
$14.93

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol ELTX
  • Company Elicio Therapeutics, Inc.
  • Price $14.2
  • Changes Percentage 4.8
  • Change 0.65
  • Day Low $12.76
  • Day High $14.2
  • Year High $14.93
  • Year Low $7.37
  • Market Cap $239,148,570
  • Price Avg 50 EMA (D) $10.86
  • Price Avg 200 EMA (D) $9.96
  • Exchange NASDAQ
  • Volume 148,075
  • Average Volume 131,598
  • Open $13.61
  • Previous Close $13.55
  • EPS -2.36
  • PE -5.31
  • Earnings Announcement 2026-08-06 04:00:00
  • Shares Outstanding $19,086,079

Company brief: ELICIO THERAPEUTICS, INC. (ELTX )

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.

ELTX Corporation News

Income Statement